Delivery Order SPE2DB20D3505-SPE2DB22FT9R2
- Not listed
- This federal contract award, SPE2DB22D1106|SPE2DB25FDVV6, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of Febuxostat 40 mg tablets. The contract has a ceiling value of $1,485.26 and a completion date of January 27, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. The IDC...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA) for the delivery of febuxostat 40 mg tablets. The $1,330.64 Firm Fixed Price delivery order contract has a completion date of January 9, 2025. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation noted. The award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,972.24 for the supply of 40 mg febuxostat tablets. The contract has an ultimate completion date of November 5, 2024 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, with an ID of SPE2DX15D1022|SPE2DX24FVMBV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, which has a ceiling value of $4,000.87, is for the delivery of FEBUXOSTAT 40 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed price delivery order, with an ultimate completion date of August 19, 2024. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of febuxostat 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,075.98 and an ultimate completion date of April 14, 2025. There was no set-aside designation for this award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with a GovTribe ID of SPE2DB22D1002|SPE2DB25FLBZ2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,699.10 firm fixed price delivery order is for the supply of 4,568,196,825 units of the medication Febuxostat 40 mg tablet. The contract has a performance period ending on May 12, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,218.55, is a Firm Fixed Price Delivery Order for the provision of FEBUXOSTAT 40 MG TABLET 30S, a pharmaceutical product. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,292.13 and an ultimate completion date of August 27, 2025. The contract carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,008.52, is for the delivery of Febuxostat 80mg tablets to support federal healthcare programs. The contract has a period of performance through March 31, 2025 and uses a firm fixed price pricing structure. This award is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,672.36 contract is for the delivery of 30-count bottles of the medication febuxostat 40 mg tablets to support military treatment facilities and other federal healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT9R2Delivery Order
The federal contract award, SPE2DB20D3505|SPE2DB22FT9R2, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.59 delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of Febuxostat 40 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of June 28, 2022. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/27/22 |